Small business backlash fueled Trump’s victory
When the Business Times asked Labor Secretary Tom Perez last spring if the Obamacare mandates, new overtime rules and other new regulations amounted to a war on small business, he dismissed us with a wave of the hand. “Predictions of disaster amount to exactly that,” he said. On Nov. 8 the disaster arrived. And it Read More →
Central Coast startups work on stuff of science fiction
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Building more affordable housing difficult for tri-county developers
Building affordable housing can be anything but affordable for developers. Developers often need some sort of subsidy for affordable projects to pencil out, given the fact that they will receive below-market rents. Yet, the arena for federal income tax credits is becoming increasingly competitive. Projects are rated on a point system for the Low-Income Housing Read More →
UCSB plans to upgrade or replace baseball stadium
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Ventura County economy faces challenges
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Status quo carries the day in Tri-Counties
The political earthquake that upended national politics triggered few aftershocks on the Central Coast. That’s the easiest way to summarize the results of races up and down the ballot in the tri-county region, where outsiders dreaming of an upset funneled millions of Democratic and Republican dollars into races for Congress and the Assembly. A number Read More →
Amgen’s Humira biosimilar delayed, Enbrel approved
Amgen’s Humira biosimilar Amjevita will be delayed at least through 2017 due to litigation by competitor AbbVie. The maker of Humira filed a patent infringement claim against Amgen on Aug. 4, alleging that the drug also violates the Biosimilar Price Competition and Innovation Act. Amgen was approved to market its biosimilar Sept. 23 by the Read More →
